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Abstract
The 39 splice site of influenza A segment 7 is used to produce mRNA for the M2 ion-channel protein, which is critical to the
formation of viable influenza virions. Native gel analysis, enzymatic/chemical structure probing, and oligonucleotide binding
studies of a 63 nt fragment, containing the 39 splice site, key residues of an SF2/ASF splicing factor binding site, and
a polypyrimidine tract, provide evidence for an equilibrium between pseudoknot and hairpin structures. This equilibrium is
sensitive to multivalent cations, and can be forced towards the pseudoknot by addition of 5 mM cobalt hexammine. In the
two conformations, the splice site and other functional elements exist in very different structural environments. In particular,
the splice site is sequestered in the middle of a double helix in the pseudoknot conformation, while in the hairpin it resides
in a two-by-two nucleotide internal loop. The results suggest that segment 7 mRNA splicing can be controlled by
a conformational switch that exposes or hides the splice site.
Citation: Moss WN, Dela-Moss LI, Kierzek E, Kierzek R, Priore SF, et al. (2012) The 39 Splice Site of Influenza A Segment 7 mRNA Can Exist in Two Conformations: A
Pseudoknot and a Hairpin. PLoS ONE 7(6): e38323. doi:10.1371/journal.pone.0038323
Editor: Alfred Lewin, University of Florida, United States of America
Received March 22, 2012; Accepted May 3, 2012; Published June 7, 2012
Copyright:  2012 Moss et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health (NIH) R01 GM22939. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: turner@chem.rochester.edu
. These authors contributed equally to this work.
Introduction
Pandemic outbreaks of influenza A were responsible for millions
of deaths in the 20
th century. Notably, the Spanish Flu of 1918
killed between 20 [1] and 100 million people [2]. Influenza is still
of grave concern to public health. Each year globally there are an
estimated three to five million severe infections with up to 500,000
deaths [3]; in the U.S. alone there are approximately 200,000
hospitalizations and 36,000 deaths yearly [4,5,6]. Most therapeu-
tics target influenza proteins: e.g. blocking the M2 ion channel
with amantadine and rimantadine [7]). The virus, however,
utilizes RNA at every step in its propagation, making viral RNA
an attractive target for therapeutic treatment [8,9]. A better
understanding of the structure and function of RNA in influenza A
would open new avenues for treatment of this deadly disease, and
provide a valuable complement to current therapeutics.
The influenza A virus possesses an eight segment (–) sense RNA
genome, which codes for at least eleven proteins. Fragments of the
influenza A coding RNA are predicted to have unusual
thermodynamic stability, and also have suppressed third codon
position variability. In combination with conserved base pairing,
these results provided predictions of fragments likely to fold into
functional structures [10]. One particularly interesting fragment
(Fig. 1) includes the 39 splice site of segment 7, as well as key
residues of a binding site for the human SF2/ASF splicing factor
[11] and a polypyrimidine tract that may bind other splicing
factors such as U2AF65 [12,13]. Segment 7 encodes the M1
matrix protein and three alternatively spliced products that share
the 39 splice site: the M2 protein, the small M3 polypeptide, and
occasionally M4 [14]. Production of M2 is critical for uncoating of
the viral genome and splicing of the M2 mRNA is temporally
controlled [15].
Secondary structure modeling of the 39 splice site of segment 7
(Fig. 1) yielded the possibility of two alternative conformations: (1)
a pseudoknot (Fig. 1B), where the splice site is base paired in a helix
and (2) a hairpin (Fig. 1C), where the splice site occurs in a two-by-
two nt internal loop [10]. Native gel analysis, enzymatic/chemical
structure probing, and oligonucleotide binding studies reported
here for a 63 nt fragment are consistent with these models. A
similar hairpin/pseudoknot was described for the 39 splice site of
segment 8, which was proposed to influence splicing of the NS2
mRNA [16,17]. These results suggest that splicing of segment 7
may be modulated by varying splice site accessibility [18,19,20,21]
or splicing factor binding [22,23,24], and that conformational
switching may be a common mechanism to control splicing of
influenza genes. Small molecules [25,26,27,28,29] or oligonucleo-
tides [30,31,32] that specifically bind to these structures could be
used to test their function and potentially provide leads for
therapeutics.
Results
Native Gel Electrophoresis Reveals Two Conformations
Native gels were run with a 63 nt fragment of an avian influenza
A3 9 splice site (3PSS) from segment 7, alongside an artificial
mutant construct (HPMut) that can fold into a hairpin but not
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changed to adenosines (Fig. 1B) and the two hairpin CG pairs at
nucleotides 716–734 and 717–733 are swapped to make GC pairs
(Fig. 1C); both changes forbid formation of the pseudoknot P0
helix while maintaining the hairpin. When the wild type sequence
is folded in the presence of Mg
2+, two bands are observed (Fig. 2A).
The faster running of the two major bands observed for 3PSS
(lanes 4–9 of Fig. 2A) migrates similar to HPMut (lane 1 of Fig. 2A).
This suggests that the faster running band is the hairpin (HP)
conformation of 3PSS and, by exclusion, that the slower running
band is the pseudoknot (PK) conformation.
In the absence of multivalent cations there is no observable
amount of PK (Fig. 2A lane 3; 2B lane 1). In the presence of Mg
2+,
3PSS folds into both HP and PK conformations (Fig. 2A) but even
with 25 mM Mg
2+ PK never becomes dominant (Fig. 2A lane 9).
However, when 3PSS is incubated with 5 mM cobalt (III)
hexammine ([Co(NH3)6]
3+), the dominant product becomes PK
(Fig. 2B, lane 7). Henceforth, 3PSS will be referred to as PK when
in the presence of 5 mM [Co(NH3)6]
3+ and as HP when in the
presence of only 100 mM KCl.
Enzymatic and Chemical Mapping of RNA Secondary
Structure
To study individual conformations, mapping was carried out
on 3PSS with 100 mM KCl and no multivalent cations to favor
HP, and with 100 mM KCl and 5 mM [Co(NH3)6]
3+ to favor
PK. HPMut was mapped in 100 mM KCl with 10 mM MgCl2.
PK and HP/HPMut share structural motifs P1, P2, and
junction J1/2 (Fig. 3). The differences between the two
conformations are the P0 and P39 motifs in PK and the P3
stem-loop in HP/HPMut. Enzymatic mapping used RNase T1
(cleaves after unpaired G), RNase A (cleaves after unpaired C
and U), and RNase If (cleaves after any single stranded
nucleotide). Chemical mapping used DMS (methylates N1 of A
and N3 of C when unpaired), CMCT (modifies N3 of U and
N1 of G when unpaired), and DEPC (modifies an exposed N7
of A) [33]. Pb
2+ cleavage [34,35] and SHAPE mapping [36]
were used to identify flexible regions.
In 5 mM [Co(NH3)6]
3+, where PK dominates, the P0 stem
region, which incorporates the 39 splice site, is not reactive
(Fig. 3A). Of the three nucleotides that bridge P0 and P1, A687 is
modified by SHAPE and A688 is modified by DMS. There are no
strong hits on the P1 hairpin. Reactivity is clustered in the J1/2
junction and the 59 end of the P39 hairpin. The J1/2 junction is
cleaved by RNase If,P b
2+ and modified by SHAPE and DMS.
The P39 hairpin is quite sensitive to enzymatic cleavage, but less so
towards small molecules. RNases If, T1, and A cleave along the 59
end of P39, whereas the loop region is modified by DEPC at A724
and A730. PK is largely protected from Pb
2+ cleavage (Fig. 4A,B).
After incubation in Pb(OAc)2 for 4 min, strong cleavage only
occurs at the J1/2 junction, particularly at A704 (Fig. 4B).
Figure 1. Location and structure of the 39 splice site. (A) Segment 7 mRNA annotated with the splice sites (red arrow), UTRs (yellow box), and
M1 and M2 open reading frames. M1 and M2 share the same start site, but M1 stops within the M2 ORF (at the black dotted line). Splicing combines
the two green boxes to form the M2 open reading frame. (B) Predicted pseudoknot (PK) model with 39 splice site annotation (red arrow), an SF2/ASF
exonic splicing enhancer binding site in orange, and a polypyrimidine tract in blue. (C) Predicted hairpin (HP) model with same annotations as B. In
order to isolate a single conformation, specific mutations were introduced to change nts 684 to 686 into A’s and to swap GC for CG at pairs 716–734
and 717–733 to forbid the pseudoknot and only allow the hairpin fold (HPMut).
doi:10.1371/journal.pone.0038323.g001
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Even after 60 min of incubation, PK is un-reactive outside these
regions (Fig. 4A,B).
In the absence of multivalent cations, where HP dominates, P1
has many enzymatic cleavages and small molecule modification
sites (Fig. 3B and S1). The J1/2 junction of HP is reactive with
most reagents, particularly including DEPC. The loop of the P3
hairpin is sensitive to RNase T1, DMS, SHAPE, and DEPC.
There is a strong DEPC modification at the A730 bulge. After
a 4 min incubation in Pb(OAc)2, HP has a strong Pb
2+ cleavage
after G703 in J1/2 (Figs. 3B and 4B). After 8 min of incubation in
Pb(OAc)2, HP is cleaved at nearly every nucleotide (Fig. 4A).
Though reactivity with Pb
2+ is widespread, the most intense
cleavage (G703) has only about 67% the highest intensity observed
in PK or HPMut (Fig. 4B).
3PSS folded in 10 mM Mg
2+ yields both HP and PK in roughly
equal amounts (Fig. 2A lane 7). 3PSS folded under these
conditions was also probed (Fig. S1E). The reactivity observed
under these conditions is consistent with both PK and HP being
present. This, along with the native gel analysis, verifies the
presence of both conformations when 3PSS folds in the presence
of Mg
2+.
To further test the presumed hairpin secondary structure,
mapping was also carried out on HPMut in the presence of
Figure 2. Native gels of 3PSS and HPMut under various conditions. (A) First lane is HPMut folded with 10 mM Tris (pH7), 100 mM KCl, and
10 mM MgCl2; the second lane is 3PSS with 10 mM Tris (pH7) and no monovalent or divalent ions. The remaining lanes are for 3PSS with 10 mM Tris
(pH7) and 100 mM KCl with increasing Mg
2+ concentration (0, 2.5, 5.0, 7.5, 10, 15, and 25 mM). (B) First lane is 3PSS with 10 mM Tris (pH7), 100 mM
KCl and no multivalent ions. The remaining lanes are 3PSS with 10 mM Tris (pH7) and 100 mM KCl with increasing [Co(NH3)6]
3+ concentration (0.002,
0.01, 0.02, 0.1, 2.5, and 5 mM).
doi:10.1371/journal.pone.0038323.g002
Figure 3. Mapping results for 3PSS and HPMut. The reagents are indicated by shape and color (see figure key). Only strong hits, with $2/3 the
highest intensity band in a lane after subtraction of intensity from the control lane, are annotated. Pb
2+ mapping results are taken from 4 min
incubation time. For Pb
2+, strong hits had $2/3 the intensity of A704 from PK, the strongest band observed under any condition at 4 min incubation
time. Boxed residues are the center nucleotide of sites binding strongly ($1/3 the highest intensity spot) and unambiguously to microarray probes
(i.e. without alternative binding sites capable of forming stable duplexes within 3 kcal/mol of the optimal binding site). All folding buffers contained
10 mM Tris (pH7), 100 mM KCl. (A) Mapping results for 3PSS folded in 5 mM [Co(NH3)6]
3+ (PK). (B) Mapping results for 3PSS folded without Mg
2+ or
[Co(NH3)6]
3+ (HP). RNase A reactivity is not annotated because RNA is over-digested at the same enzyme concentration that yielded good results in
PK and HPMut (Fig. S3). (C) Mapping results for HPMut folded in 10 mM Mg
2+.
doi:10.1371/journal.pone.0038323.g003
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2+ (Fig. 3C). The P1 hairpin has strong RNases If, T1,
and A cleavage sites. There is also a DMS modification at A688,
similar to HP. The J1/2 junction has RNases If and T1 cleavages
and SHAPE and Pb
2+ modification sites. A719 in the AU pair
flanking the A730 bulge is modified by DMS. The loop of P3 is
modified strongly by DMS, CMCT, SHAPE, and DEPC and also
cleaved by RNase T1. SHAPE and DMS modify the A730 bulge.
When normalized by the most intense cleavage in PK (A704), the
Pb
2+ cleavage pattern for HPMut is similar to that seen for HP,
but the single dominant cleavage is at A705 (Figs. 3C and 4B).
After 15 min of incubating in Pb(OAc)2, HPMut is cleaved at
nearly every nucleotide (Fig. 4A). HPMut folded in 100 mM KCl
and 5 mM [Co(NH3)6]
3+was also probed with RNAse A, T1, and
Pb
2+; results were similar to those with 100 mM KCl and 10 mM
Mg
2+ (Fig. S1C).
Accessibility to Short Oligonucleotides
PK, HP, and HPMut were hybridized to microarrays with 861
chimeric pentamer and hexamer oligonucleotides containing 29-
O-methyl RNAs with locked nucleic acid (LNA) and 2,6-
diaminopurine modifications at selected positions to roughly
equalize the thermodynamic stability of hybridization to un-
structured RNA [37,38,39,40]. Results for probes with five
consecutive nucleotides Watson-Crick complementary to 3PSS
are listed in Table S1. Hairpin P1 is strongly bound under all
conditions tested (Fig. 3). The probes invade more of the P1 stem
in HP and HPMut than in PK, however. PK also strongly binds to
a probe that invades the P39 helix (Fig. 3A). HPMut strongly binds
to probes centered at the bulged A730 of P3 (Fig. 3C) and at G736
and U737 on one side of the internal loop that contains the 39
splice site.
Secondary Structure is Conserved
Based on the structure probing experiments and the expanded
sequence alignment used in this study (Table S2), small changes
are proposed for the model versus the one previously proposed
[10]. The changes in the structures are shifting of nucleotides in P1
(the bioinformatics model had C700 bulged) and the revised
pairing of A713 to U737 in the pseudoknot, which grew P2 at the
expense of P0 (Fig. 1). A base pair is also added between U718 and
A735 in P39. The hairpin and pseudoknot were initially presented
as alternative secondary structures, but both are observed in
solution (Fig. 2).
Both conformations of the 39 splice site are well conserved
throughout the alignment of all unique Influenza A sequences. All
helices are greater than 92% conserved and canonical pairing, on
average, is 95% conserved (Table S2). Every helix has at least one
consistent or compensatory mutation (Fig. 5). When mutations led
to non-canonical pairs, they were most often CA (2.9%) or GA
pairs (1.3%). These CA and GA pairs occur mainly in the middle
of helices: e.g. pair 691–700 in P1, 711–739 in P2, and 720–729 in
P3 (Fig. 5, Table S2). Other types of non-canonical pairs were
rarely observed (Table S2).
Base Pair and GC Pair Content Correlates with Host
Species
On average, the pseudoknot structures expected to be most
stable have 18 canonical base pairs, 50% of which are GC pairs
(Table S3). The structures expected to be least stable have, on
average, 16 canonical base pairs and only 31% of them are GC
pairs. When clustered by the fraction of GC pairs and canonical
pairs, five groups are apparent (Fig. 6). The number of unique
sequences that fall within each cluster follows a bell-shaped
distribution (Fig. 6). The stable clusters have sequences that
allow for a greater number of canonical pairs and, in particular,
GC pairs. For example, across all unique sequences, positions
684 and 715 are most often UG pairs, but in the stable clusters
they are primarily CG pairs. Conversely, the less stable clusters
are comprised of sequences that do not allow for as many
canonical and GC pairs. Positions 711 and 739, for example,
Figure 4. Pb
2+ mapping results. (A) Gel images of PK (5 mM [Co(NH3)6]
3+), HP (no multivalent ions), and HPMut (10 mM Mg
2+) incubated with
1 mM Pb(OAc)2, 10 mM Tris (pH 7), and 100 mM KCl for 0, 0.5, 1, 2, 4, 8, 15, 30, and 60 min. (B) integrated band densities at each nucleotide
normalized to the strongest band observed under any condition (A704 from PK) at 4 min incubation time. RNA structure is annotated below each
graph where paired nucleotides that form complementary helical strands are indicated by colored boxes.
doi:10.1371/journal.pone.0038323.g004
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these positions are mostly AC pairs (Table S2). The hairpin
structure metrics globally follow that of the pseudoknot (Table
S3).
The fraction of GC and canonical pairs in the pseudoknot and
hairpin structures correlates with the fraction of influenza A
sequences that infect a given host species (Fig. 6 and Table S3).
Avian strains make up 82% of the most GC and base pair rich
sequences, but only 26% of the sequences with lower content. The
opposite trend holds for sequences that infect humans and swine:
only 9% of the most GC and base pair rich sequences infect
humans (another 9% for swine), while 48% of the sequences with
lower base pair and GC content are human specific (23% are
swine specific; Fig. 6).
Discussion
Influenza remains a public health problem [41] and is also
a potential agent for bioterrorism [42,43,44]. Current therapeutics
target influenza proteins [45]. RNA, which is used throughout
influenza replication, is an attractive alternative target. The results
presented here show that a fragment of influenza A segment 7 can
fold into two different conformations: a hairpin, HP, and
a pseudoknot, PK. The predicted free energies of HP and PK
are 216.9 kcal/mol and 216.3 kcal/mol, respectively. This small
difference in free energy predicts that the equilibrium constant for
the two conformations is close to 1. Both conformations have
significant concentrations when Mg
2+ is present (Fig. 2), consistent
with the predicted free energy difference between them. Stabiliz-
ing the free energy by as little as 1.5 kcal/mol, which can be
supplied by one or two hydrogen bonds, will shift the equilibrium
constant by a factor of 10. Thus, small perturbations, such as
protein binding, can push the equilibrium to one conformation.
Switching between HP and PK may have a role in the regulation
of splicing and this suggests that these RNA structures have
potential as therapeutic targets.
Conformational Switching has Implications for Function
The presence of two conformations has implications for
function, as each conformation places several functional elements
in different structural contexts. In 3PSS, the pseudoknot may
make the sequences required for molecular recognition inacces-
sible to splicing elements; whereas, in the hairpin conformation,
these elements are less constrained by structure and are pre-
sumably better able to interact with splicing factors. The most
obvious case is sequestration of the splice site in P0 of PK versus
exposing it in a two-by-two nt internal loop in HP. A similar
equilibrium between hairpin and pseudoknot structures occurs
within the 39 splice site of segment 8 of influenza A and B and has
been proposed to play a role in the regulation of splicing [16,17].
The segment 8 structures are different, but also place the splice site
in paired or unpaired structural contexts, potentially modulating
splicing by hiding or revealing the splice site. This may be
a common mechanism to control splicing: For example, seques-
tration of cryptic 39 splice sites in pseudoknots of the yeast actin
mRNA [46] and Sd.cob,1 group I intron [47] acts to suppress
splicing at these sites.
The region surrounding the 39 splice site of segment 7 also
contains the key residues of the SF2/ASF exonic splicing enhancer
binding site in the purine rich stretch from nucleotides 723 to 738
[11]. These residues form different hairpins, P3 and P39,i nH P
and PK, respectively (Fig. 1). Additionally, a polypyrimidine tract
occurs at nucleotides 696 to 702, which form the 39 half of hairpin
P1. In the absence of multivalent cations P1 is extremely reactive,
including stem positions, indicating that P1 may be particularly
unstable (Fig. 3B). Roles for splice site RNA structure in regulating
splicing, e.g. by hiding and revealing splice sites or protein binding
sites, have been described for other RNAs [48]. In particular,
RNA conformational switching can be induced by proteins [49,50]
or small molecules [51,52] to regulate splicing. Expression of M2
protein is known to occur late in viral infection [15]. Perhaps
changes in the cellular environment over time: such as pH, protein
binding, or the presence of metabolites could affect the 39 splice
Figure 5. Consensus sequence and structure. (A) PK and (B) HP. Canonical pairs are indicated with solid bars and putative non-canonical pairs
with dashed lines. Stem mutations that preserve base pairing are colored green for single (consistent) point mutations and blue for double
(compensatory) point mutations when they occur in five or more sequences. Mutations with implications for non-canonical pairs are indicated in
grey. Potential base triples are indicated with orange dashed lines. The exact interaction between the base pair and loop residue, however, cannot be
inferred from available data. Putative helical stacking is indicated with a blue dashed line.
doi:10.1371/journal.pone.0038323.g005
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increased production of M2 mRNA.
Increased Mg
2+ allows for some pseudoknot folding, but even
25 mM Mg
2+ cannot push the equilibrium completely to
pseudoknot (Fig. 2A). Addition of [Co(NH3)6]
3+, however,
preferentially stabilizes the 3PSS pseudoknot (Fig. 2B). Preferable
binding of [Co(NH3)6]
3+ to pseudoknots over hairpins by 3 to 5
fold has been described [53,54]. Compared to hexahydrated
magnesium, [Co(NH3)6]
3+ has a similar size but a higher charge
density, allowing for stronger interactions with RNA [55,56]. The
particular affinity of [Co(NH3)6]
3+ to pseudoknots has been
attributed to the tendency of pseudoknots to have pockets of high
negative charge at the intersection of adjacent pseudoknot helices
and/or connecting loops [53]. NMR studies on a viral frameshift
pseudoknot showed that [Co(NH3)6]
3+ binds tightly to a divalent
metal binding pocket formed by a two nucleotide loop and the
major groove of a nearby helix [54].
Cobalt hexamine is also able to bind motifs containing GA pairs
and can do so more strongly than Mg
2+ [57]. Interestingly, one of
the distinguishing features of the 3PSS pseudoknot is the possibility
of forming multiple GA pairs in P39: a single GA within the P39
helix, and three tandem GA pairs in the terminal loop (Figs. 3A
and 5A). When mutations occur in this loop, they are most often to
another purine base (Fig. 5A and Table S2). Evidence for the
strength of the interaction between PK and [Co(NH3)6]
3+ can be
inferred from the strong stops observed in primer extension on
3PSS folded in [Co(NH3)6]
3+ (Fig. S2 lanes 5 to 8). Even though
samples were washed in 70% ethanol and heated to 90uC, the
reverse transcriptase is unable to read through the strong
secondary structure of P39 stabilized by the remaining
[Co(NH3)6]
3+.
Implications from Results of Mapping RNA Structures
P1 is more accessible to enzymes in HP and HPMut than in PK.
Even at low RNase If concentrations P1 is reactive in HP (Fig. 3B
and Fig. S3 lane 5). At medium enzyme concentration, HP is
extremely reactive in the P1 region (Fig. S3 lane 4). Conversely, P1
of PK is not strongly reactive, even in the loop region, at the
highest enzyme concentration (Fig. 3A and Fig. S3 lane 15).
Additionally, the loop of P1 in PK is not strongly reactive with
RNase A and T1, but is strongly reactive in HPMut (Fig. 3). This
difference is unlikely to arise from changes in buffer: HPMut
folded in 5 mM [Co(NH3)6]
3+ also has a strong RNase A and T1
cleavage in the P1 loop (Fig. S1C). HP is extremely reactive to
RNAse A in the P1 region: at even the lowest enzyme
concentration it is mostly degraded (Fig. S3 lane 8). These results
indicate that P1 might be less accessible to proteins, such as
splicing factors, in the pseudoknot conformation, but more
accessible in the hairpin structure. P1 is expected to be less stable
in HP than in PK because the ends are unrestricted upon P1
unfolding in HP. This provides a more favorable entropy change
for unfolding in HP than in PK. In general, an open, flexible,
polypyrimidine tract is better able to bind splicing factors [49,58].
Interestingly, P1 of HPMut is reactive to RNase V1, which cleaves
double stranded or stacked RNA, and also to reagents that are
Figure 6. Histogram of all unique influenza A sequences grouped by expected stability of pseudoknot mutations. The stability metric
is calculated as the fraction of nucleotides that are canonically paired, multiplied by the fraction of GC pairs. Above each bar is a pie chart that gives
the percentage of sequences that infect a given host. Other/Mixed strains are those where the majority of sequences infected an animal from other
than human, swine, or avian species; or where they could infect more than one type of host species.
doi:10.1371/journal.pone.0038323.g006
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strongly hit by both RNAse If and V1. These results suggest that
the base pairs in P1 of HPMut are dynamic and may be
‘‘breathing.’’ This suggests the same dynamics for HP, although
this cannot be directly proven because V1 requires Mg
2+.
A striking feature of the Pb
2+ cleavage results (Fig. 4) is the
dramatic difference in reactivity for PK compared to HP and
HPMut. In general, PK is much less reactive to Pb
2+, except in J1/
2. This effect does not appear to be due to competition between
Pb
2+ and the [Co(NH3)6]
3+ used to fold PK; HPMut, when folded
in 5 mM [Co(NH3)6]
3+ has wide-spread reactivity (Fig. S1C) that
is more similar to HP in 100 mM KCl. The strongest Pb
2+
cleavages are in the J1/2 regions of PK and HPMut: specifically at
A704 and A705 of PK and HPMut, respectively (Fig. 4B). J1/2 of
HP is also sensitive to Pb
2+ cleavage, yet there are no cleavages as
intense as in PK or HPMut. Perhaps when the RNA is folded in
the absence of multivalent cations (HP) a specific binding pocket
for lead, such as in tRNA [59] and in a group I intron [60], may
no longer form. DEPC modifies the N7 position of adenosine,
which can participate in tertiary contacts. Notably, J1/2 in HP is
strongly reactive to DEPC but J1/2 is not strongly reactive in PK
and HPMut where multivalent ions are present. This provides
further evidence for a potential tertiary fold for J1/2.
Except for the RNase T1 hit at G723, the loop of P3 in HP and
HPMut is insensitive to enzymes, but quite reactive with small
molecules (Fig. 3B and C and Fig. S1B, C, and D). Reactivity in
the P3 helix is confined to the bulge loop at A730, and a single
DMS hit at A719 of HPMut, where A719 is paired, but in a weak
structural context. In contrast, P39 is very sensitive to enzyme
cleavage (Fig. 3A and Fig. S1A). An unusual feature of P39 is that
the greatest reactivity occurs at the 59 side of the hairpin and
includes three residues involved in base pairs (Fig. 3A). P39 has
fewer stretches of canonical pairs than any other region of PK as
well as several putative non-canonical pairs (Fig. 5A). P39 may be
structurally dynamic. Indeed, breaking base pairs in P39 would be
necessary to transition to the hairpin conformation. This structure
may be tuned to easily open and facilitate conformational
switching.
It may be possible to target either or both of the conformations
of 3PSS with short oligonucleotides in order to modulate biological
function or for potential therapeutic applications. The results of
oligonucleotide microarray mapping show that the hybridization
behavior of PK, HPMut and HP are distinct (Fig. 3, Fig. S1, and
Table S1). Though the binding results are influenced by buffer
conditions, which are not physiological, the strong binding centers
for the probes suggest regions for targeting with oligonucleotides.
The small hexamer and pentamer binding sites may be used as
nucleation sites for the binding of larger oligonucleotides such as
siRNAs [61] or shRNAs [62].
Conservation of Structure
The HP and PK conformations are well conserved throughout
influenza A strains. They span a region that is under strict selective
pressure: it must maintain open reading frames for M1 and, after
nt 714, the M2 protein open reading frame, as well as protein
binding sites [11]. Mutations must also maintain RNA secondary
structure (Fig. 5). Conservation is also favored by the influenza
encoded polymerase, which has higher fidelity than most viral
polymerases [63]. The high conservation of structure in the region
containing the 39 splice site of segment 7 makes this region an
attractive therapeutic target. Moreover, the presence of small loops
favors approaches for rational selection of molecules as lead
compounds [28,29,31]. The microarray results (Fig. 3 and Table
S1) suggest that short oligonucleotides may also be used to inhibit
correct splicing. Similarly, the M1 protein amino acids encoded by
3PSS may be attractive targets for antiviral agents, as their
evolution is also strictly constrained by the need to maintain
functional sites and structure in both the protein and RNA.
Mutations from canonical to non-canonical pairs in the 3PSS
region are rare (Table S2). When they occur they are in the middle
of stems, where they might be less disruptive to structure. Indeed,
only two types of non-canonical pairs have significant numbers at
sites predominantly canonically paired (Table S2): CA pairs, which
can maintain A form helices [64], followed by GA pairs, which can
substitute for canonical pairs in phylogenetically conserved
structures [65,66,67]. Conversely, at sites where putative non-
canonical pairs predominate, mutations occur most often to form
canonical pairs or other putative non-canonical interactions (Fig. 5
and Table S2). For example: in P39, nucleotides 719 and 734 are
most often AG, but the most frequently observed mutation
converts this to a UG pair (Fig. 5A and Table S2). Imino AG and
canonical UG pairs both present an amino group in the minor
groove, which can be used for molecular recognition [68,69,70].
Three consecutive GA pairs are possible in the terminal loop of
P39 (Fig. 5A). When mutations occur they maintain purines at
each side of the helix. This sequence pattern is common in internal
loops, where it results in three consecutive purine-purine sheared
pairs [71]. In HP the two-by-two nucleotide internal loop may
contain non-canonical interactions as well. G736 frequently
changes to a U, allowing it to pair with G714 (Fig. 5B) and
positions 715 and 735 are always purines: GA or GG, which have
been observed to form interactions in other RNAs [72,73].
Interestingly, internal loops comprised of GG and GA are
observed in the ribosomal loop E motif [74] and in the HIV-1
Rev protein binding element [75]; in both cases the loop plays
important roles in protein recognition.
Another conserved feature in the structural model and
alignment (Fig. 5A and Table S4) is the possibility of forming
base triples at G687(C712-G738), U686(A713-U737) and (C685-
G714)G736 in PK. UAU and CGG are the most common base
triples in known 3D structures of RNA [76]. Sequence variations
at these positions could maintain potential triple interactions
(Table S4). Because of the close proximity of stems and loops, such
loop-helix interactions are commonly found in pseudoknots
[77,78,79] and can play important roles in stabilizing structure
[80]. These putative triples occur at the intersection of the P0 and
P2 pseudoknot helices, which may form a coaxial stacking
interaction where G714 is stacked on A713 and U737 is stacked
on C685 (Fig. 5A). The same type of stacking interaction, where
pseudoknot helices coaxially stack with AU on CG, is observed in
a bacteriophage mRNA pseudoknot [81,82].
Host species distribution of number of canonical pairs
and GC pair content. 3PSS sequences segregated into five
groups based on their canonical base pair and GC pair content.
The composition of each cluster varied dramatically by the host
specificity of the influenza A strain (Fig. 6): the greater the strength
of the structure, as gauged by the overall base pair density and
number of GC pairs, the higher the fraction of avian vs. human
strains. The swine specific strains fell somewhere between human
and avian. These trends may be explained by the temperatures
encountered where influenza replicates. Temperatures for the
avian gut, swine and human respiratory tract are 41uC, 37uC, and
33uC, respectively [83]. Perhaps the higher number of canonical
and GC pairs in avian strains occurs to maintain the pseudoknot
and hairpin structures, or their ratio, at higher temperatures.
Conversely, at the lower temperatures found in swine and human
hosts, there is less pressure to stabilize these structures. The host
specificity of the observed changes in the 39 splice site region may
Influenza A Segment 7 RNA Splice Site Structure
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stability. A study of all available influenza A coding regions found
that there were global trends in RNA folding free energy and, in
general, avian sequences were more stable than swine or human
[84]. Additionally, four of the eight influenza A segments,
including segment 7, showed evidence for globally conserved
RNA secondary structure [84]. Interestingly, the strength of this
global structure also favored avian sequences.
Methods
Production of 3PSS and HPMut RNAs
DNA templates for 3PSS and HPMut RNAs, including T7
promoter sites were ordered from IDT Inc. The 3PSS sequence
was selected from the GC pair rich cluster and is found in four
avian sequences of mixed strains (GenBank accessions: CY081301,
CY021470, CY014592, DQ107463). HPMut has an identical
sequence except where mutations were introduced to abolish the
pseudoknot: positions 684-6 (mutated to unpaired adenosines) and
716-7/733-4 (two hairpin CG pairs swapped to GC). In vitro
transcription reactions were performed using an Ampliscribe T7-
Flash Transcription kit (Epicentre). Products were purified by
denaturing PAGE and electroeluted in a Bio-Rad Model 422
electro-eluter. RNAs were 59 end labeled with c-
32P ATP (Perkin
Elmer), then re-purified by denaturing PAGE.
RNA Folding for Native Gel Analysis
For each sample, about 100,000 cpm of 59 end labeled RNA
was heated in water to 90uC for 2 min and slowly cooled to 50uC
in a thermocycler. Tris and KCl were added to a final
concentration of 10 mM Tris (pH 7) and 100 mM KCl, at
50uC, for all samples. To study the multivalent cation dependent
folding of 3PSS, MgCl2 was added to get a range of final
concentrations from 2.5 to 25 mM and, in separate samples
without Mg
2+, [Co(NH3)6]Cl3 was added to span 0.002 to 5 mM.
HPMut was folded with a final concentration of 10 mM MgCl2 or
5 mM [Co(NH3)6]
3+ at 50uC. All samples were then slow cooled
from 50uCt o3 7 uC where they remained for 15 min before
placing them on ice. Folding was analyzed by native gel
electrophoresis. Glycerol loading buffer (3 mL) was added to each
sample and about 20,000 cpm of folded RNA (2 mL) was run per
lane on a non-denaturing 6% polyacrylamide gel made with 1X
THEM (34 mM Tris Base, 57 mM HEPES, 0.1 mM EDTA,
10.0 mM MgCl2) buffer. The gel was run using 16THEM
running buffer, at low Wattage (15 W), at 4uC in order to
maintain folding [85]. After 6.5 h, the gel was dried, exposed to
a phosphorscreen, and imaged using a Bio-Rad Personal
Molecular Imager.
Chemical and Enzymatic Mapping
RNAs used in all mapping experiments were folded as described
for native gel analysis. Each sample had a final buffer and
monovalent ion composition of 10 mM Tris (pH 7) and 100 mM
KCl. HPMut contained 10 mM Mg
2+ or 5 mM [Co(NH3)6]
3+,P K
5 mM [Co(NH3)6]
3+ and HP no multivalent ions. Enzymatic and
small molecule mapping was carried out at room temperature.
RNase If, A, T1, and V1 reactions, alkaline hydrolysis and
RNase T1 ladder were adapted from manufacturer’s protocol
(Ambion, Inc and New England Biolabs) and carried out on 59 end
labeled RNAs (50,000 cpm per reaction). Optimal enzymatic
concentrations were determined with enzyme titrations. The
digestion reactions were stopped by ethanol precipitation at
220uC. The resulting pellet was dissolved in gel loading buffer
and fractionated on a denaturing, 8% polyacrylamide gel.
Pb
2+ cleavage reactions were carried out by incubating 59 end
labeled RNAs with 1 mM Pb(OAc)2 [86,87]. Aliquots
(50,000 cpm per aliquot) were removed at 0, 0.5, 1, 2, 4, 8, 15,
30, and 60 min. The reaction was stopped by placing the aliquots
in gel loading buffer and freezing at 280uC until they were
fractionated on a denaturing, 8% polyacrylamide gel. DEPC
reactions were carried out by incubating 59 end labeled RNAs
(50,000 cpm per reaction) with 0.69 mM DEPC, followed by
NaBH4 reduction and aniline cleavage. Reactions were stopped
by precipitation at 220uC and the resulting pellet was dissolved in
gel loading buffer and fractionated on a denaturing, 8% poly-
acrylamide gel.
Unlabeled 3PSS RNA (0.5 mg per reaction) was modified with
optimized concentrations of DMS, CMCT, and NMIA using
published protocols [87,88]. Modifications were read out by
primer extension (primer sequence: 59-ACATCTGCACTCCC-
39, chemically synthesized by IDT, and 59 end labeled with c-
32P
ATP) with 100, 000 cpm per reaction, followed by separation of
fragments by denaturing 8% PAGE.
All gels were dried, exposed to phosphorscreen, and imaged
with a Bio-Rad Personal Molecular Imager. Gel images were
analyzed with ImageJ [89]. Bands were quantified by taking the
integrated pixel density and normalizing with respect to the
highest intensity band after subtraction of background observed in
negative controls, which were treated as for reactions, but with
omission of the modifying reagent. For Pb
2+ cleavage, equal
amounts of radioactivity were loaded in each lane and so all bands
were normalized to A704 of PK, which was the most intense in
any gel.
Hybridization to Oligonucleotide Microarrays
About 200,000 cpm of labeled RNA was folded as described
above before hybridization to oligonucleotide microarrays
[32,38,90,91]. Each of the 861 probes was spotted in triplicate.
Spotting buffer, monomer U, and pentamer UUUUU, which
should show no binding to 3PSS, were also printed on the
microarray as internal negative controls. Hybridizations were
carried out in folding buffer for 18 h at 4uC. Microarrays were
washed for 1 min at 0uC and then dried by centrifugation.
Hybridization was visualized by exposure to a phosphorimager
screen and quantitative analysis was performed with ArrayGau-
geV2.1. Binding was considered strong, medium and weak, when
the integrated intensities were $1/3, $ 1/9 and $ 1/27 of the
strongest integrated intensity, respectively. Alternative binding
sites were predicted using RNA-RNA thermodynamics [92,93].
Sequence Alignment and Analysis
All full-length, non-redundant influenza A sequences (13,277)
were downloaded from the National Center for Biotechnology
Information (NCBI) influenza virus resource page [94]. An
alignment was generated with the MAFFT alignment algorithm’s
FFT-NS-1 method [95]. The 3PSS region was cut from the large
alignment and sequence duplicates were collapsed using a PERL
script to identify 734 unique sequences. The nucleotide alignment
was converted to amino acids in silico, re-aligned with ClustalW
[96], manually refined, then converted back into nucleotides. Base
pairing frequencies from each model (Fig. 3A,B) were analyzed
with respect to the whole alignment and each unique sequence
using PERL scripts.
Free energies at 37uC were predicted for the hairpin and
pseudoknot conformations with a nearest neighbor thermody-
namic model [92,93,97,98] and pseudoknot loop entropy model
[99].
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Figure S1 Results of experimental mapping. Specific
reagent is indicated by colored shapes (see figure key). Reactivity
$2/3 the strongest band is indicated with solid shapes, while
reactivity ,2/3 but $1/3 the strongest band is indicated by open
shapes. All folding buffers contained 10 mM Tris (pH7), 100 mM
KCl. Mapping results for: (A) 3PSS folded in 5 mM [Co(NH3)6]
3+
(PK). (B) 3PSS folded without Mg
2+ or [Co(NH3)6]
3+ (HP) RNase
A reactivity is not annotated because RNA is over-digested at the
same enzyme concentration that yielded good results in PK and
HPMut. (C) HPMut folded in 5 mM [Co(NH3)6]
3+, and mapped
with Pb
2+ and RNases A and T1. (D) HPMut folded in 10 mM
Mg
2+.( E) 3PSS folded in 10 mM Mg
2+ which gives roughly equal
amounts of PK and HP. Results are annotated on both structure
models (SHAPE mapping was not performed on the mixture).
RNase V1 was only used when folding conditions contained Mg
2+,
which is essential to enzyme activity [82]. Dark and light orange
letters represent strong and moderate RNase V1 hits.
(TIF)
Figure S2 Gel results for primer extension. Readouts of
DMS, kethoxal, and CMCT experiments on pseudoknot (PK),
hairpin (HP), and hairpin mutant (HPMut) are shown. The first
four lanes are dideoxy ladders and the remaining are for
experiments on each RNA target. Unmodified RNA experimental
controls (Exp. Control) were run alongside each set of experiments
to show natural stops induced by target structure. Interpretable
primer extension data for PK stretches from nts 683 to 715.
(TIF)
Figure S3 Gel results for enzymatic mapping experi-
ments on HP and PK. T1 ladders and hydrolysis ladders (OH
ladders) are run alongside mapping lanes to identify cleavage sites.
For each enzyme the black wedge indicates the increasing range of
enzyme used: RNase If had 50 U, 5 U, 0.5 U; RNase A had 1 ng,
0.1 ng and 0.01 ng; and RNAse T1 had 1 U, 0.1 U, and 0.01 U.
The last lane is an experimental control for RNA treated the same
as enzyme reactions, but without any enzyme.
(TIF)
Table S1 Table of results for microarray hybridization
experiments.
(XLSX)
Table S2 Base pairing frequencies and percent canon-
ical pairing. Pseudoknot (PK) and hairpin (HP) conformation
counts based on an alignment of unique sequences and also all
available sequences. Data for PK and the helixes P1 and P2 in HP
are shown in the top box. The P3 helix of HP is shown in the
bottom box. Paired sites are indicated by the i and j locations of
the 59 and 39 nts. Symmetric loop sites are given in italics. Helixes
are colored purple for P0, orange for P1, green for P2, and blue for
P3/P39. Mutations expected to be compensatory (double point
mutations that preserve pairing) are annotated in blue. Mutations
expected to be consistent (single point mutations that maintain
pairing) are annotated in green. The last column gives the
percentage of the time i and j are canonically paired in the
alignment of all unique sequences. Also included are the base pair
type percentages by helix and averaged across helices.
(XLSX)
Table S3 Table with GenBank accession numbers and
sequences used in this study. Unique sequences are ranked
according to their ability to form stable secondary structure. The
most stable are at the top, while the least stable are at the bottom.
Relative stability is estimated as the fraction of GC pairs multiplied
by the fraction of nucleotides in canonical pairs (color annotated
red to green for both PK and HP). Also shown are the number of
sequences that collapse into each unique sequence, the host
specificity and the viral strain.
(XLSX)
Table S4 Counts for putative base triples. The most
frequent triple is in red and the second most frequent in orange.
(XLSX)
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